The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer

scientific article

The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1016257982
P356DOI10.1245/S10434-011-2125-1
P932PMC publication ID3884694
P698PubMed publication ID22048633

P2093author name stringJames R Goldenring
Min-A Kim
Han-Kwang Yang
Woo Ho Kim
Hyuk-Joon Lee
Ki Taek Nam
Yun-Suhk Suh
Eun-Jung Jung
P2860cites workMuc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cellsQ24291012
A novel gene activated in regenerating isletsQ24294417
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaQ27824784
A gene-expression signature as a predictor of survival in breast cancerQ27860945
Gene-expression profiles predict survival of patients with lung adenocarcinomaQ29614443
Use of a cDNA microarray to analyse gene expression patterns in human cancerQ29618814
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studiesQ30724668
Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implicationsQ31059425
Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.Q32061478
A molecular signature of gastric metaplasia arising in response to acute parietal cell lossQ33317849
Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancerQ33557996
Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasiaQ33750475
Intestinal cell adhesion molecules. Liver-intestine cadherinQ33934218
Clinical significance of dysadherin expression in gastric cancer patientsQ34315548
Inactivation of the E-cadherin-mediated cell adhesion system in human cancersQ35753235
Galectin-4 in normal tissues and cancerQ35759428
Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors.Q35817618
The galectin family and digestive diseaseQ37108003
Role of DNA methylation in the development of diffuse-type gastric cancerQ37832910
Galectins as cancer biomarkersQ38105320
Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancerQ39651684
The role of Reg IV gene and its encoding product in gastric carcinogenesisQ39801619
Molecular mechanisms of cell adhesion in normal and transformed cellsQ39819944
Reg IV enhances peritoneal metastasis in gastric carcinomasQ39895385
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapyQ40180989
Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinomaQ40387409
Overexpression of MUC13 is associated with intestinal-type gastric cancerQ40420359
De-novo expression of CD44 and survival in gastric cancerQ42483834
Tumour suppressor gene expression correlates with gastric cancer prognosisQ44401645
Histologic heterogeneity and mucin phenotypic expression in early gastric cancer.Q50505727
Japanese Classification of Gastric Carcinoma - 2nd English Edition -Q51050338
Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.Q51597657
Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers.Q51746168
Protein expression profiling and molecular classification of gastric cancer by the tissue array method.Q51910260
Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer.Q53472187
Molecular mechanism of stomach carcinogenesis.Q53483428
Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.Q54469747
E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegrationQ70611377
Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancerQ73592530
Molecular characterization of undifferentiated-type gastric carcinomaQ73757919
MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicatorsQ77357135
Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinomaQ81249390
P433issue4
P921main subjectbiomarkerQ864574
P304page(s)1240-1249
P577publication date2011-11-03
P1433published inAnnals of Surgical OncologyQ2853069
P1476titleThe combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer
P478volume19

Reverse relations

cites work (P2860)
Q36677718Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway
Q26783991Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer
Q47759471Differential expression of two genes Oct-4 and MUC5AC associates with poor outcome in patients with gastric cancer
Q39500994Effects of Helicobacter pylori infection on MUC5AC protein expression in gastric cancer
Q38841122Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling
Q31125021Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer
Q49361058Long non-coding RNA CAT104 promotes cell viability, migration and invasion in gastric carcinoma cells through activation of microRNA-381 inhibiting zinc finger E-box binding homeobox 1 (ZEB1) expression
Q36131557Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach
Q38268568Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.
Q41673477Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer
Q36186928Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis
Q57280332PTK7 as a novel marker for favorable gastric cancer patient survival
Q51029933Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer.
Q49527958Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer
Q36085609Prognostic value of Muc5AC in gastric cancer: A meta-analysis
Q36355626Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers
Q36529179Single nucleotide polymorphisms in the CDH17 gene of colorectal carcinoma
Q28543901Upregulation of autophagy-related gene-5 (ATG-5) is associated with chemoresistance in human gastric cancer

Search more.